IVI and Italy
From 2006 to 2011, Italy’s Costante Ceccarini served on the IVI Scientific Advisory Group.
University of Siena
In 2017, IVI, the Institute for Global Health at the Siena University of Italy and Incheon National University (INU) of Korea launched an Executive Master Program in Public Health, Biotechnology and Pharmaceutical Clinical Development.
The joint program is an extension of the University of Siena’s Executive Master in Vaccinology and Pharmaceutical Clinical Development. While the master’s program in Siena focuses exclusively on vaccines, the joint Master’s degree with IVI and INU broadens the scope to include the pharmaceutical development of small molecules and biologicals beyond vaccines.